103 related articles for article (PubMed ID: 29932149)
21. The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults.
Alonso-Cotoner C; Abril-Gil M; Albert-Bayo M; Mall JG; Expósito E; González-Castro AM; Lobo B; Santos J
Adv Ther; 2021 May; 38(5):2054-2076. PubMed ID: 33738725
[TBL] [Abstract][Full Text] [Related]
22. Health Potential of
Ceravolo I; Mannino F; Irrera N; Squadrito F; Altavilla D; Ceravolo G; Pallio G; Minutoli L
Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33672553
[TBL] [Abstract][Full Text] [Related]
23. Modulation of NLRP3 Inflammasome Attenuated Inflammatory Response Associated to Diarrhea-Predominant Irritable Bowel Syndrome.
Scuderi SA; Casili G; Lanza M; Filippone A; Paterniti I; Esposito E; Campolo M
Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33233503
[TBL] [Abstract][Full Text] [Related]
24. Treatment with Luteolin Improves Lipopolysaccharide-Induced Periodontal Diseases in Rats.
Casili G; Ardizzone A; Lanza M; Gugliandolo E; Portelli M; Militi A; Cuzzocrea S; Esposito E; Paterniti I
Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33096800
[TBL] [Abstract][Full Text] [Related]
25. Properties of a New Food Supplement Containing
Lanza M; Casili G; Torre GL; Giuffrida D; Rotondo A; Esposito E; Ardizzone A; Rando R; Bartolomeo G; Albergamo A; Vadalà R; Salvo A
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33019631
[TBL] [Abstract][Full Text] [Related]
26. Topical Delivery of Curcumin by Choline-Calix[4]arene-Based Nanohydrogel Improves Its Therapeutic Effect on a Psoriasis Mouse Model.
Filippone A; Consoli GML; Granata G; Casili G; Lanza M; Ardizzone A; Cuzzocrea S; Esposito E; Paterniti I
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708987
[TBL] [Abstract][Full Text] [Related]
27. Urinary tract infections in the elderly: a review of disease characteristics and current treatment options.
Rodriguez-Mañas L
Drugs Context; 2020; 9():. PubMed ID: 32699546
[TBL] [Abstract][Full Text] [Related]
28. Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis.
Campolo M; Casili G; Paterniti I; Filippone A; Lanza M; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438777
[TBL] [Abstract][Full Text] [Related]
29. Oligosaccharides and Complex Carbohydrates: A New Paradigm for Cranberry Bioactivity.
Coleman CM; Ferreira D
Molecules; 2020 Feb; 25(4):. PubMed ID: 32079271
[TBL] [Abstract][Full Text] [Related]
30. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview.
Piqué N; Berlanga M; Miñana-Galbis D
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126033
[TBL] [Abstract][Full Text] [Related]
31. Randomized, placebo-controlled trial of xyloglucan and gelose for the treatment of acute diarrhea in children.
Santos J; Musta V; Luca CM; Belei OA; Cambrea SC
Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):325-331. PubMed ID: 33028102
[TBL] [Abstract][Full Text] [Related]
32. A case of urinary tract infection due to Salmonella enterica serovar Virchow and review of the related literature.
Gulcan A; Bayram P; Levent B; Gulcan E
Acta Microbiol Immunol Hung; 2012 Mar; 59(1):85-9. PubMed ID: 22510290
[TBL] [Abstract][Full Text] [Related]
33. Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections.
Esposito E; Campolo M; Casili G; Lanza M; Franco D; Filippone A; Peritore AF; Cuzzocrea S
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932149
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Xyloglucan against Escherichia coli Extraintestinal Urinary Tract Infection: An in vivo Study.
Esposito E; Campolo M; Casili G; Lanza M; Franco D; Fazio E; Filippone A; Paterniti I; Cuzzocrea S
Microb Physiol; 2020; 30(1-6):50-60. PubMed ID: 33070135
[TBL] [Abstract][Full Text] [Related]
35. Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview.
Piqué N; Gómez-Guillén MDC; Montero MP
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495535
[TBL] [Abstract][Full Text] [Related]
36. Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults.
Costache RC; Novac B; Bardan TR; Agapie DN; Edu A
Urol Int; 2019; 102(4):468-475. PubMed ID: 30889607
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
